GC WellBeing Corporation (KOSDAQ:234690)
10,750
+1,520 (16.47%)
At close: Sep 3, 2026
GC WellBeing Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Operating Revenue | 192,210 | 164,680 | 133,805 | 120,535 |
Other Revenue | -0 | -0 | - | -0 |
| 192,210 | 164,680 | 133,805 | 120,535 | |
Revenue Growth | 35.53% | 23.08% | 11.01% | - |
Cost of Revenue | 113,496 | 91,363 | 69,044 | 57,797 |
Gross Profit | 78,714 | 73,317 | 64,761 | 62,738 |
Selling, General & Admin | 54,266 | 48,885 | 44,027 | 44,679 |
Research & Development | 5,448 | 5,786 | 5,936 | 6,005 |
Amortization of Goodwill & Intangibles | 551.47 | 653.46 | 542.14 | 544.95 |
Other Operating Expenses | 192.13 | 180.43 | 183.63 | 193.01 |
Operating Expenses | 61,178 | 56,023 | 51,797 | 52,281 |
Operating Income | 17,537 | 17,294 | 12,964 | 10,457 |
Interest Expense | -4,244 | -3,541 | -1,934 | -1,657 |
Interest & Investment Income | 179.81 | 421.91 | 335.13 | 219.2 |
Earnings From Equity Investments | -4,016 | -2,320 | -819.9 | -588.47 |
Currency Exchange Gain (Loss) | 26.69 | -36.65 | 44.51 | -55.31 |
Other Non Operating Income (Expenses) | -1,633 | 2,151 | -979.44 | -94.71 |
EBT Excluding Unusual Items | 7,850 | 13,970 | 9,610 | 8,281 |
Gain (Loss) on Sale of Investments | 69.27 | -64.14 | -67.45 | -33.47 |
Gain (Loss) on Sale of Assets | -920.3 | -1,321 | 0.77 | 2.02 |
Pretax Income | 6,999 | 12,585 | 9,544 | 8,249 |
Income Tax Expense | 1,509 | 2,574 | 2,474 | 1,501 |
Net Income | 5,490 | 10,011 | 7,069 | 6,748 |
Net Income to Common | 5,490 | 10,011 | 7,069 | 6,748 |
Net Income Growth | -34.32% | 41.61% | 4.76% | - |
Shares Outstanding (Basic) | 18 | 18 | 18 | 18 |
Shares Outstanding (Diluted) | 19 | 20 | 18 | 18 |
Shares Change | -0.06% | 10.44% | -0.03% | - |
EPS (Basic) | 309.80 | 564.14 | 398.32 | 380.11 |
EPS (Diluted) | 268.45 | 486.11 | 398.00 | 380.11 |
EPS Growth | -40.02% | 22.14% | 4.71% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | -10,702 | 2,035 | 12,219 | -1,971 |
Free Cash Flow Per Share | -573.79 | 103.81 | 688.47 | -111.05 |
Dividend Per Share | 140.000 | 140.000 | 120.000 | 100.000 |
Dividend Growth | 16.67% | 16.67% | 20.00% | - |
Gross Margin | 40.95% | 44.52% | 48.40% | 52.05% |
Operating Margin | 9.12% | 10.50% | 9.69% | 8.68% |
Profit Margin | 2.86% | 6.08% | 5.28% | 5.60% |
Free Cash Flow Margin | -5.57% | 1.24% | 9.13% | -1.64% |
EBITDA | 23,604 | 23,291 | 18,385 | 15,876 |
EBITDA Margin | 12.28% | 14.14% | 13.74% | 13.17% |
D&A For EBITDA | 6,068 | 5,997 | 5,422 | 5,419 |
EBIT | 17,537 | 17,294 | 12,964 | 10,457 |
EBIT Margin | 9.12% | 10.50% | 9.69% | 8.68% |
Effective Tax Rate | 21.57% | 20.46% | 25.93% | 18.20% |
Advertising Expenses | - | 9,215 | 6,978 | 9,435 |